Blood-membrane interaction in hemodialysis leads to increased cytokine production
- PMID: 3498081
- DOI: 10.1038/ki.1987.175
Blood-membrane interaction in hemodialysis leads to increased cytokine production
Abstract
Recently much interest has been focused on the role of immunoregulatory cytokines such as interleukin 1 (IL 1) and interleukin 2 (IL 2) during the pathogenesis of immunological as well as inflammatory diseases. Therefore peripheral blood mononuclear cells (PBMC) of eight patients undergoing hemodialysis (HD) were tested for IL 1 and IL 2 production. Before starting HD, cytokine production by PBMC in culture was not altered in comparison to normal healthy controls, however, a significant increase of IL 1 and IL 2 production was observed within the first HD hour which lasted throughout the end of HD. Moreover direct effects of cellulose membranes on PBMC cytokine production as well as serum IL 1 levels have been investigated. Serum IL 1 levels were already elevated before onset of HD and increased further during HD. The discrepancy between PBMC IL 1 production and serum IL 1 levels may be due to the diminished excretion in patients with end-stage renal disease. Since addition of dialysis membrane particles enhanced monocytes to produce more IL 1 as well as lymphocytes to release more IL 2, a direct stimulatory membrane effect is postulated. The increased release of immunoregulatory cytokines may account for some of the pathologic findings observed during hemodialysis.
Similar articles
-
The effects of hemodialysis (HD) membranes on interleukin 1-beta (IL-1 beta) production from peripheral blood mononuclear cells (PBMC).Clin Nephrol. 1995 Nov;44 Suppl 1:S24-8. Clin Nephrol. 1995. PMID: 8608657
-
Effects of dialyzer membrane on interleukin-1beta (IL-1beta) and IL-1beta-converting enzyme in mononuclear cells.Kidney Int Suppl. 2001 Feb;78:S282-5. doi: 10.1046/j.1523-1755.2001.59780282.x. Kidney Int Suppl. 2001. PMID: 11169027 Clinical Trial.
-
Altered interleukin-1 production in patients undergoing hemodialysis.Nephron. 1988;50(4):277-81. doi: 10.1159/000185187. Nephron. 1988. PMID: 3266310
-
Cytokine production in patients on dialysis.Blood Purif. 1995;13(3-4):135-46. doi: 10.1159/000170196. Blood Purif. 1995. PMID: 7619385 Review.
-
Functional changes in immunocompetent cells induced by direct cell/membrane interactions in dialysis.Contrib Nephrol. 1990;86:111-20. doi: 10.1159/000419371. Contrib Nephrol. 1990. PMID: 2078947 Review. No abstract available.
Cited by
-
Induction of tumour necrosis factor-alpha during haemodialysis. Influence of the membrane type.Clin Exp Immunol. 1991 Feb;83(2):329-32. doi: 10.1111/j.1365-2249.1991.tb05637.x. Clin Exp Immunol. 1991. PMID: 1993364 Free PMC article.
-
Impact of long-term hemodialysis on nutritional status in patients with end-stage renal failure.Clin Investig. 1994 Oct;72(10):754-61. doi: 10.1007/BF00180542. Clin Investig. 1994. PMID: 7865978 Clinical Trial.
-
Monitoring of inflammation in patients on dialysis: forewarned is forearmed.Nat Rev Nephrol. 2011 Mar;7(3):166-76. doi: 10.1038/nrneph.2011.2. Nat Rev Nephrol. 2011. PMID: 21358695 Review.
-
Inflammasome assembly is required for intracellular formation of β2-microglobulin amyloid fibrils, leading to IL-1β secretion.Int J Immunopathol Pharmacol. 2022 Jan-Dec;36:3946320221104554. doi: 10.1177/03946320221104554. Int J Immunopathol Pharmacol. 2022. PMID: 35615856 Free PMC article.
-
Comparing risk of new onset diabetes mellitus in chronic kidney disease patients receiving peritoneal dialysis and hemodialysis using propensity score matching.PLoS One. 2014 Feb 4;9(2):e87891. doi: 10.1371/journal.pone.0087891. eCollection 2014. PLoS One. 2014. PMID: 24504072 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical